PDS Biotech to Announce Q4 and Year-End Financial Results and Provide Clinical Programs Update on March 30, 2026.

Tuesday, Mar 24, 2026 4:07 pm ET1min read
PDSB--

PDS Biotech will host a conference call and webcast on March 30, 2026, at 8:00 am ET to report financial results for the quarter and year ended December 31, 2025. The company will provide a clinical programs and corporate update. PDS Biotech is a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers. Its lead program is in advanced HPV16-positive head and neck squamous cell cancers, and it has initiated a pivotal clinical trial.

PDS Biotech to Announce Q4 and Year-End Financial Results and Provide Clinical Programs Update on March 30, 2026.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet